Home / Brands / Teva Pharmaceuticals USA
Teva Pharmaceuticals USA Recalls
279 recalls on record · June 27, 2012 to May 13, 2026 · Drugs
Recalls by year
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
June 10, 2015DrugsFDA
Teva Pharmaceuticals USA recalls Zebeta¿ (bisoprolol fumarate), tablets, 10mg, 30-count bottle, Rx only, Manufactured for Teva Pharmaceuticals Inc. 425 P
Hazard: Failed Dissolution Specifications: OOS result during stability testing
June 3, 2015DrugsFDA
Teva Pharmaceuticals USA recalls QVAR (beclomethasone dipropionate HFA 40 mcg), 40 mcg Inhalation Aerosol, For Oral Inhalation with QVAR Actuator Only,
Hazard: Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing.
May 6, 2015DrugsFDA
Teva Pharmaceuticals USA recalls Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50
Hazard: Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
May 6, 2015DrugsFDA
Teva Pharmaceuticals USA recalls Fluoxetine Capsules USP, 10 mg, in 100-count bottles, Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A.,
Hazard: Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
November 5, 2014DrugsFDA
Teva Pharmaceuticals USA recalls DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets, (CII), 1
Hazard: Failed Impurities/Degradation Specifications: Out of specification for unknown impurities.
August 20, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only, Manufactured in Israel by Teva Pharmaceutic
Hazard: Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.
August 6, 2014DrugsFDA
Teva Pharmaceuticals USA recalls triple therapy, LANSOPRAZOLE DR Capsules USP 30mg, CLARITHROMYCIN Tablets USP 500mg, AMOXICILLIN Capsules USP 500mg, 8 c
Hazard: Failed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obtained during stability testing for Lansoprazole.
July 23, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0
Hazard: Failed Impurities/Degradation Specifications: out of specification impurity test results.
July 23, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Kariva (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispensers
Hazard: Failed Impurities/Degradation Specifications: out of specification impurity test results.
July 23, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Mircette (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispenser
Hazard: Failed Impurities/Degradation Specifications: out of specification impurity test results.
July 23, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva
Hazard: Failed Impurities/Degradation Specifications: out of specification impurity test results.
July 16, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by T
Hazard: Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.
July 2, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, ND
Hazard: Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.
June 4, 2014DrugsFDA
Teva Pharmaceuticals USA recalls ParaGard T 380A - Intrauterine Copper Contraceptive, 176 mg of copper wire, Duramed Pharmaceuticals Inc, a subsidiary of
Hazard: Non-sterility: due to a failed sterility test
May 28, 2014DrugsFDA
Teva Pharmaceuticals USA recalls QVAR¿ (beclomethasone dipropionate HFA), 80mcg Inhalation Aerosol, 50 metered inhalations/120 metered inhalations, packa
Hazard: Defective Delivery System; defective valve
May 28, 2014DrugsFDA
Teva Pharmaceuticals USA recalls BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 8 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville,
Hazard: Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.
May 28, 2014DrugsFDA
Teva Pharmaceuticals USA recalls BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 2 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville,
Hazard: Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.
May 21, 2014DrugsFDA
Teva Pharmaceuticals USA recalls INDOMETHACIN Capsules USP, 50 mg, a) 100 count bottle, (NDC 0093-4030-01), b) 500 count bottle, (NDC 0093-4030-05), Manu
Hazard: CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.
May 21, 2014DrugsFDA
Teva Pharmaceuticals USA recalls INDOMETHACIN Capsules USP, 25 mg 100 count bottle, Rx only , Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmac
Hazard: CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
May 21, 2014DrugsFDA
Teva Pharmaceuticals USA recalls GLYBURIDE and METFORMIN HYDROCHLORIDE Tablets USP, 5mg/500mg, 500 count bottle, Manufactured In INDIA By: EMCURE PHARMAC
Hazard: CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
May 21, 2014DrugsFDA
Teva Pharmaceuticals USA recalls METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceu
Hazard: CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
May 7, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Compa
Hazard: Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
May 7, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Fluoxetine Capsules USP, 20 mg, packaged in a) 100-count bottles (NDC 50111-648-01), b) 500-count bottles (NDC 50111-648
Hazard: Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
April 9, 2014DrugsFDA
Teva Pharmaceuticals USA recalls QVAR¿ (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mktd by: Teva Respiratory, LLC, Ho
Hazard: Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point
April 9, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharma
Hazard: Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.
April 9, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharma
Hazard: Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.
April 9, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx Only, 60 capsules per Bottle, Manufactured in Israel by: Teva Pharma
Hazard: Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.
March 12, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sell
Hazard: CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
March 12, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Teva Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII,
Hazard: CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg were manufactured using unapproved material: the finished product was not properly quarantined as rejected due to inadequate cleaning of equipment.
March 12, 2014DrugsFDA
Teva Pharmaceuticals USA recalls Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sell
Hazard: CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.